+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
MALE
ID06754423

Registry Study of Adult Males With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2024-12-31

30

Participants Needed

1

Research Sites

27 weeks

Total Duration

AI-Summary

What This Trial Is About

This observational cohort study focuses on male patients with Congenital Adrenal Hyperplasia CAH due to 21-hydroxylase deficiency. It includes both newly diagnosed patients and those previously diagnosed at other centers, covering all stages of the disease. The study aims to create an electronic registry to better understand the incidence and prevalence of this rare condition, particularly in the Emilia Romagna region. Participants will be monitored through laboratory tests and imaging studies that follow standard clinical care practices. The study includes a retrospective phase enrolling patients diagnosed from 1960 onward and a prospective phase for ongoing observation. Both phases together aim to enroll about 30 male patients, with some contributing to retrospective data only. Throughout the study, patients will undergo routine clinical evaluations as part of their care. Data collected will include medical history, laboratory results, and imaging findings. The primary outcome is the establishment of a comprehensive electronic registry, with observations extending until the end of 2032. Participation involves no additional interventions beyond standard care.

CONDITIONS

Brief Title

Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency

Research Team

A

Alessandra Gambineri, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here